Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1-Reference-Cited by-同舟云学术

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1

Published:2012-09 Issue:3 Volume:57 Page:534-540
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ogawa Eiichi,Furusyo Norihiro,Murata Masayuki,Ikezaki Hiroaki,Ihara Takeshi,Hayashi Takeo,Toyoda Kazuhiro,Taniai Hiroaki,Okada Kyoko,Kainuma Mosaburo,Hayashi Jun

Publisher

Elsevier BV

Subject

Hepatology

Reference32 articles.

1. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

2. Natural history of chronic hepatitis C;Seeff;Hepatology,2002

3. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia;Hayashi;J Infect Dis,2000

4. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

5. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C;Tanaka;Nat Genet,2009

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

2. HCV treatment with direct acting antivirals improves the insulin sensitivity;Expert Review of Anti-infective Therapy;2019-08-17

3. Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment;European Journal of Gastroenterology & Hepatology;2019-01

4. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance;Virulence;2017-03-27

5. Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C;Infectious Agents and Cancer;2016-02-24